COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,884 Articles (22,568 medRxiv, 8,316 bioRxiv)

Most recent first Previous |  Page 990: Articles 9891-9900  | Next

Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individuals.
De Marco, L., D'Orso, S., Pirronello, M., Verdiani, A., Termine, A., Fabrizio, C., Capone, A., Sabatini, A., Guerrera, G., Placido, R., Sambucci, M., Angelini, D. F., Giannessi, F., Picozza, M., Caltagirone, C., Salvia, A., Volpe, E., Balice, M. P., Rossini, A., Rotzschke, O., Giardina, E., Battistini, L., Borsellino, G.
10.1101/2021.12.30.474453 — Posted: 2021-12-30
Unsupervised genome-wide cluster analysis: nucleotide sequences of the omicron variant of SARS-CoV-2 are similar to sequences from early 2020
Hahn, G., Lee, S., Prokopenko, D., Novak, T., Hecker, J., Khurana, S., Baden, L. R., Randolph, A. G., Weiss, S. T., Lange, C.
10.1101/2021.12.29.474469 — Posted: 2021-12-30
Viral population genomics reveals host and infectivity impact on SARS-CoV-2 adaptive landscape
Gayvert, K., Copin, R., McKay, S., Setliff, I., Lim, W. K., Baum, A., Kyratsous, C. A., Atwal, G. S.
10.1101/2021.12.30.474516 — Posted: 2021-12-30
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies
Tada, T., Zhou, H., Dcosta, B. M., Samanovic, M. I., Chivukula, V., Herati, R., Hubbard, S. R., Mulligan, M. J., Landau, N. R.
10.1101/2021.12.28.474369 — Posted: 2021-12-30
Pipeline for retrieval of COVID-19 immune signatures
Newton, A. J. H., Chartash, D., Kleinstein, S. H., McDougal, R. A.
10.1101/2021.12.29.474353 — Posted: 2021-12-30
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Li, C., Zhan, W., Yang, Z., Tu, C., Zhu, Y., Song, W., Huang, K., Gu, X., Kong, Y., Zhang, X., Zhang, M., Zhang, Y., Xie, Y., Deng, Q., Chen, Z., Lu, L., Jiang, S., Sun, L., Wu, Y., Ying, T.
10.1101/2021.12.30.474535 — Posted: 2021-12-30
Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant
Cui, Z., Liu, P., Wang, N., Wang, L., Fan, K., Zhu, Q., Wang, K., Chen, R., Feng, R., Jia, Z., Yang, M., Zhu, B., Fu, W., Chu, T., Feng, L., Wang, Y., Pei, X., Yang, P., Xie, X. S., Cao, L., Cao, Y. R., Wang, X.
10.1101/2021.12.29.474402 — Posted: 2021-12-30
Forecasting COVID-19 infection trends and new hospital admissions in England due to SARS-CoV-2 Variant of Concern Omicron
Gerli, A. G., Centanni, S., Soriano, J. B., Ancochea, J.
10.1101/2021.12.29.21268521 — Posted: 2021-12-30
Short-term Projections based on Early Omicron Variant Dynamics in England.
Keeling, M. J., Brooks-Pollock, E., Challen, R. J., Danon, L., Dyson, L., Gog, J. R., Guzman-Rincon, L., Hill, E. M., Pellis, L. M., Read, J. M., Tildesley, M.
10.1101/2021.12.30.21268307 — Posted: 2021-12-30
The rich-to-poor vaccine donation game: When will self-interested countries donate their surplus vaccines during pandemics?
Lampert, A., Sulitzeanu-Kenan, R., Vanhuysse, P., Tepe, M.
10.1101/2021.12.30.21268537 — Posted: 2021-12-30 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).